Muscle Adiposity and Body Fat Distribution in Type 1 and Type 2 Diabetes: Varying Relationships According to Diabetes Type
Overview
Affiliations
Objective: To compare the relationships between markers of total and regional adiposity with muscle fat infiltration in type 1 diabetic and type 2 diabetic subjects and their respective nondiabetic controls, and to document these relationships in type 1 diabetic subjects.
Design: Cross-sectional study.
Subjects: In total, 86 healthy, with type 1 diabetes, type 2 diabetes or control subjects. Each diabetic group was matched for age, sex and body mass index with its respective nondiabetic control group.
Measurements: Measures of body composition (hydrodensitometry), fat distribution (waist circumference, abdominal and mid-thigh computed tomography scans) and blood lipid profiles were assessed.
Results: Low attenuation mid-thigh muscle surface correlated similarly with markers of adiposity and body composition in all groups, regardless of diabetes status, except for visceral adipose tissue and waist circumference. Indeed, relationships between visceral adiposity and muscle adiposity were significantly stronger in type 2 vs type 1 diabetic subjects (P<0.05 for comparison of slopes). In addition, in well-controlled type 1 diabetic subjects (mean HbA(1c) of 6.8%), daily insulin requirements tended to correlate with low attenuation mid-thigh muscle surface, a specific component of fat-rich muscle (r=0.36, P=0.08), but not with glycemic control (HbA(1c)).
Conclusion: This study suggests that the relationship of central adiposity and muscle adiposity is modulated by diabetes status and is stronger in the insulin resistant diabetes type (type 2 diabetes). In well-controlled nonobese type 1 diabetic subjects, the relationship between muscle fat accumulation and insulin sensitivity was also maintained.
Aging adipose tissue, insulin resistance, and type 2 diabetes.
Zhao Y, Yue R Biogerontology. 2023; 25(1):53-69.
PMID: 37725294 DOI: 10.1007/s10522-023-10067-6.
Ogawa M, Hashimoto Y, Mochizuki Y, Inoguchi T, Kouzuma A, Deguchi M Exp Physiol. 2023; 108(7):975-985.
PMID: 37133323 PMC: 10988481. DOI: 10.1113/EP090655.
Han S, Jeon Y, Park G, Lee T, Park S, Yu G Endocrinol Metab (Seoul). 2021; 36(4):855-864.
PMID: 34376042 PMC: 8419614. DOI: 10.3803/EnM.2021.1086.
Ko J, Skudder-Hill L, Cho J, Bharmal S, Petrov M World J Gastroenterol. 2021; 27(23):3357-3371.
PMID: 34163117 PMC: 8218354. DOI: 10.3748/wjg.v27.i23.3357.
Adamo M, Codella R, Casiraghi F, Ferrulli A, Macri C, Bazzigaluppi E Cell Transplant. 2016; 26(1):23-32.
PMID: 27983910 PMC: 5657693. DOI: 10.3727/096368916X693022.